Company Overview

Founded in 2001 with the goal of developing innovative antibody-based therapeutics to treat cancer, the name ABXIS is a reflection of our dedication to become an axis of antibody (Ab) therapeutics.

Our pipeline also includes rare disease therapeutics, in addition to the anti-cancer therapeutics that we developed on our way to becoming a leading biotechnology company in Korea. By providing new ways of combatting cancer and rare diseases, ISU ABXIS will fulfill its vision of enhancing the lives and easing the suffering of patients worldwide.


ISU ABXIS is a biotechnology company dedicated to the development of new and novel bio-therapeutics that will enhance the lives and ease the suffering of patients struggling with cancer and rare diseases.

ISU Core Purpose

Creating a beautiful future with abundance and convenience

Challenge the Future Share the Future

ISU Core Values


  • Passion We have confidence in ourselves and seek for positive ways to make the impossible possible.
  • Achievement We persistently push ourselves to be at our best despite difficulties and challenges and achieve our goals.
  • Autonomy and Responsibility We own our outcomes and show our values in our actions and performances.
  • Innovation We are unconstrained the way things we have always been done and find new ways to transform the concept of game rules.


  • Developed the 1st Antibody Drug in South Korea

  • Launched 3 Products Developed Independently

  • Research Focused on Oncology and Rare Disease

  • 6 Projects in the R&D Pipeline

  • GMP Manufacturing Facility Operation of 3 Suites